WO2009043577A3 - 19-nor-progesterone zur kontrazeption - Google Patents
19-nor-progesterone zur kontrazeption Download PDFInfo
- Publication number
- WO2009043577A3 WO2009043577A3 PCT/EP2008/008342 EP2008008342W WO2009043577A3 WO 2009043577 A3 WO2009043577 A3 WO 2009043577A3 EP 2008008342 W EP2008008342 W EP 2008008342W WO 2009043577 A3 WO2009043577 A3 WO 2009043577A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- contraceptive
- compounds
- progesterones
- methods
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Die Erfindung betrifft Verbindungen der allgemeinen Formel (I). Verfahren zu deren Herstellung, pharmazeutische, kosmetische Zusammensetzungen oder Darreichungsformen, welche diese Verbindungen enthalten, sowie Verfahren zur Kontrazeption durch Verabreichung dieser Verbindungen.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007047608.8 | 2007-10-04 | ||
| DE102007047608A DE102007047608A1 (de) | 2007-10-04 | 2007-10-04 | 19-nor-Progesterone zur Kontrazeption |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009043577A2 WO2009043577A2 (de) | 2009-04-09 |
| WO2009043577A3 true WO2009043577A3 (de) | 2009-06-25 |
Family
ID=40377693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2008/008342 Ceased WO2009043577A2 (de) | 2007-10-04 | 2008-10-02 | 19-nor-progesterone zur kontrazeption |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20090093448A1 (de) |
| DE (1) | DE102007047608A1 (de) |
| WO (1) | WO2009043577A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012058463A2 (en) * | 2010-10-27 | 2012-05-03 | Dignity Health | Trimegestone (tmg) for treatment of preterm birth |
| US10568900B1 (en) | 2013-03-15 | 2020-02-25 | Suzanne Janine Paxton-Pierson | Androgen effectors |
| US9737609B2 (en) * | 2014-08-20 | 2017-08-22 | Professional Compounding Centers Of America (Pcca) | Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1152105B (de) * | 1961-11-15 | 1963-08-01 | Schering Ag | Verfahren zur Herstellung eines wasserloeslichen Gestagens |
| EP0808845A2 (de) * | 1996-05-22 | 1997-11-26 | Roussel-Uclaf | Neue 1- oder 6-hydroxylierte Steroide, ein Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamenten und pharmazeutische Präparate davon |
| DE102005034498A1 (de) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Orale Kontrazeption mit Trimegeston |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6667050B1 (en) * | 1999-04-06 | 2003-12-23 | Galen (Chemicals) Limited | Chewable oral contraceptive |
-
2007
- 2007-10-04 DE DE102007047608A patent/DE102007047608A1/de not_active Withdrawn
-
2008
- 2008-10-02 US US12/244,480 patent/US20090093448A1/en not_active Abandoned
- 2008-10-02 WO PCT/EP2008/008342 patent/WO2009043577A2/de not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1152105B (de) * | 1961-11-15 | 1963-08-01 | Schering Ag | Verfahren zur Herstellung eines wasserloeslichen Gestagens |
| EP0808845A2 (de) * | 1996-05-22 | 1997-11-26 | Roussel-Uclaf | Neue 1- oder 6-hydroxylierte Steroide, ein Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamenten und pharmazeutische Präparate davon |
| DE102005034498A1 (de) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Orale Kontrazeption mit Trimegeston |
Non-Patent Citations (1)
| Title |
|---|
| ALBERT E. SOBEL, PAUL E. SPOERRI: "Steryl Sulfates. I. Preparation and Properties", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 63, no. 5, 1941, pages 1259 - 1261, XP002518043 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009043577A2 (de) | 2009-04-09 |
| US20090093448A1 (en) | 2009-04-09 |
| DE102007047608A1 (de) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011012122A (es) | Derivados de tiofeno. | |
| WO2008013838A3 (en) | Pyridizinone derivatives | |
| WO2009016410A3 (en) | Chemical compounds 831 | |
| WO2008152099A3 (en) | Aryl/hetarylamides as modulators of the ep2 receptor | |
| WO2009156462A3 (en) | Organic compounds | |
| WO2007135527A3 (en) | Benzimidazolyl compounds | |
| GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
| WO2009121039A3 (en) | Administration of benzodiazepine compositions | |
| UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
| SI2150530T1 (sl) | Substituirani sulfonamidni derivati | |
| WO2007144327A3 (en) | Phenyl-pyrazole derivatives as non-steroidal glucocoricoid receptor ligands | |
| WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
| GEP20135744B (en) | Quinuclidine carbonate derivatives and medicinal compositions containing the same | |
| WO2010067078A3 (en) | 3,6-disubstituted xanthylium salts as medicaments | |
| WO2011017502A3 (en) | Linaclotide-containing formulations for oral administration | |
| WO2012048129A3 (en) | Inhibitors of polo-like kinase | |
| AU2010233994A8 (en) | Bispecific anti-ErbB-3/anti-c-Met antibodies | |
| WO2013061004A8 (fr) | Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines | |
| WO2007093880A3 (en) | Novel pyrone-indole derivatives and process for their preparation | |
| WO2011006935A3 (en) | Tetrazole derivatives | |
| WO2009013545A3 (en) | Chemical compounds | |
| TW200738627A (en) | Trialkylsilyl-indoles | |
| WO2009115084A3 (de) | Pyrrolopyrimidin-derivate und deren verwendungen | |
| WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
| WO2012075015A3 (en) | Oral metronidazole pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08802748 Country of ref document: EP Kind code of ref document: A2 |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08802748 Country of ref document: EP Kind code of ref document: A2 |